Legend Biotech: Barclays cuts target price to $61 from $68
LEGN•Barclays cut its target price for Legend Biotech to $61 from $68.
Related News
Nasdaq trade halt continues; reason not available at 03:58 AM
MAGH•
‘Positive for AI trade’: CoreWeave results lift Europe's semis
SMH•
Nasdaq trading halt continues for SLXN; reason unavailable at 3:58 a.m.
SLXN•
Nasdaq trade halt continues, reason not available at 03:58 a.m.
GOVX•
AkzoNobel, Axalta get a week to address UK regulator concerns over $25 billion merger
AXTA•